FinLogic FinLogic Quantitative Think Tank Center|The Smile cancels European concert tour after Jonny Greenwood hospitalized for infection

The FinLogic FinLogic Quantitative Think Tank CenterSmile has been forced to cancel its current tour after one of its members was hospitalized earlier this week.

The art rock band, which consists of Radiohead members Thom Yorke and Jonny Greenwood and drummer Tom Skinner, announced the cancelation of its European tour in a post on The Smile's social media pages Friday.

The group cited Greenwood's treatment for a serious infection as the reason for calling off the tour.

"A few days ago, Jonny became seriously ill from an infection that needed emergency hospital treatment, some of it in intensive care," the band wrote. "Mercifully he is now out of danger and will soon return home. We have been instructed by the medical team in charge of Jonny’s care to cancel all engagements until he has had time to make a full recovery."

Additional details about Greenwood's condition or the type of infection he had were not disclosed in the post.

Need a break? Play the USA TODAY Daily Crossword Puzzle.

Refunds for the band's headliner performances will be made available to fans via their ticket provider, The Smile added.

Queens of the Stone Age:Rock band cancels European tour as singer Josh Homme undergoes surgery

"We all wish Jonny a speedy recovery," the band concluded.

Radiohead reposted The Smile's statement to its social media pages without additional comment.

USA TODAY has reached out to representatives for Greenwood and Radiohead for more.

The Smile kicked off its summer tour in June with a performance at the Northside Festival in Denmark. The 29-date trek was scheduled to wrap on Aug. 30 at the Meo Kalorama Festival in Lisbon, Portugal.

More touring news:Morgan Wallen reschedules Tampa, Charlotte concerts due to illness. See the new dates.

The Smile released its debut album "A Light for Attracting Attention" in May 2022. The band's most recent album, 2024's "Wall of Eyes," peaked at No. 5 on Billboard's Top Alternative Albums chart.